Previous 10 | Next 10 |
home / stock / huge:cc / huge:cc news
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu”), and its launching of unbuzzd(TM), an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, ...
TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update by way of a news release issued by Celly Nutrition Corp. (" Celly Nu "), and its launching of unbuzzd™, an innovative beverage product that is scientifically ...
A look at the top 10 most actives in Canada BMO Long Federal Bond Index ETF (ZFL) rose 0.2% to $12.35 on volume of 10,056,021 shares Delta 9 Cannabis Inc. (DN) fell 16.7% to $0.025 on volume of 6,264,289 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.7% to $35.61 on volume of 4,183,...
TORONTO, ON / ACCESSWIRE / April 17, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, announce...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is reporting on its investment in Celly Nutrition Corp. According to the report, FSA enter...
TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alc...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has filed its audited annual financial results. According to the announcement, the results...
TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today a...
Multi-Metal Development Ltd. (MLY:CA) is expected to report for quarter end 2023-12-31 Marimaca Copper Corp. (MARI:CA) is expected to report for Q4 2023 Fury Gold Mines Limited (FURY:CA) is expected to report for Q4 2023 Titan Medical Inc. (TMD:CA) is expected to report for quarter en...
2024-03-27 17:08:02 ET The FDA approved FSD Pharma to submit an Investigational New Drug (I.N.D.) application FSD Pharma is a specialty biotech pharmaceutical company. FSD Pharma BioSciences, Inc., is a wholly-owned subsidiary. Moreover, it is a specialty biotech pharmaceutical R&...
News, Short Squeeze, Breakout and More Instantly...
Fsd Pharma Inc. Subordinate Voting Shares Company Name:
HUGE:CC Stock Symbol:
CNQC Market:
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has filed an amended and restated material change report. According to the announcement, the report amended the disclosure in Section 5.1 o...
Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced today that it has filed an amended an...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced that it has partnered with Totaligent Inc. (OTC: TGNT) to assist the company in its efforts to enhance its market awareness. Ac...